You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
濟川藥業(600566.SH):擬使用募集資金向全資子公司濟川有限、濟川醫學及東科製藥增資
格隆匯 10-12 18:09

格隆匯 10 月 12日丨濟川藥業(600566.SH)公佈,2020年10月12日,公司召開第九屆董事會第五次會議,審議通過了《關於公司使用募集資金向全資子公司增資的議案》,同意公司使用本次非公開發行股票募集資金向全資子公司濟川藥業集團有限公司(簡稱“濟川有限”)、濟川(上海)醫學科技有限公司(簡稱“濟川醫學”)及陝西東科製藥有限責任公司(簡稱“東科製藥”)進行增資。本次增資事項無需提交公司股東大會批准,亦不涉及關聯交易。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account